- Home
- / Syntekabio
Syntekabio
Stock Price
₩4.5 K
2024-10-29
Market Capitalization
₩67.4 B
2024-10-29
Revenue
₩3.4 B
FY, 2025
Syntekabio Summary
Company Summary
- Overview
- Syntekabio is a biotech firm. It develops genomic big data and AI drug platforms that predict and identify molecular entities for institutions, industrial companies, and government research labs.
- Type
- Public
- Status
- Active
- Founded
- 2009
- Website
- http://syntekabio.com
- Cybersecurity rating
Table of Contents
Syntekabio Financials
Summary Financials
- Revenue (Q1, 2026)
- ₩422.3M
- Gross profit (Q1, 2026)
- ₩481.4M
- Net income (Q1, 2026)
- (₩3.5B)
- Cash (Q1, 2026)
- ₩13.4B
- EBIT (Q1, 2026)
- (₩3.6B)
- Enterprise value
- $61.8B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026